IT1096804B - PHARMACEUTICAL COMPOSITIONS ACTIVE ON THE CENTRAL NERVOUS SYSTEM - Google Patents

PHARMACEUTICAL COMPOSITIONS ACTIVE ON THE CENTRAL NERVOUS SYSTEM

Info

Publication number
IT1096804B
IT1096804B IT24866/78A IT2486678A IT1096804B IT 1096804 B IT1096804 B IT 1096804B IT 24866/78 A IT24866/78 A IT 24866/78A IT 2486678 A IT2486678 A IT 2486678A IT 1096804 B IT1096804 B IT 1096804B
Authority
IT
Italy
Prior art keywords
pharmaceutical compositions
nervous system
central nervous
compositions active
active
Prior art date
Application number
IT24866/78A
Other languages
Italian (it)
Other versions
IT7824866A0 (en
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of IT7824866A0 publication Critical patent/IT7824866A0/en
Application granted granted Critical
Publication of IT1096804B publication Critical patent/IT1096804B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT24866/78A 1977-06-24 1978-06-22 PHARMACEUTICAL COMPOSITIONS ACTIVE ON THE CENTRAL NERVOUS SYSTEM IT1096804B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7719390A FR2453643A2 (en) 1977-06-24 1977-06-24 PHARMACEUTICAL COMPOSITIONS ACTIVE ON THE CENTRAL NERVOUS SYSTEM

Publications (2)

Publication Number Publication Date
IT7824866A0 IT7824866A0 (en) 1978-06-22
IT1096804B true IT1096804B (en) 1985-08-26

Family

ID=9192520

Family Applications (1)

Application Number Title Priority Date Filing Date
IT24866/78A IT1096804B (en) 1977-06-24 1978-06-22 PHARMACEUTICAL COMPOSITIONS ACTIVE ON THE CENTRAL NERVOUS SYSTEM

Country Status (3)

Country Link
CH (1) CH625122A5 (en)
FR (1) FR2453643A2 (en)
IT (1) IT1096804B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL145736A0 (en) * 1999-04-09 2002-07-25 Warner Lambert Co Combinations of gaba analogs and tricyclic compounds to treat depression

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3947579A (en) * 1974-06-03 1976-03-30 Nelson Research & Development Company Method and composition for potentiating neuroleptic drugs
US3978216A (en) * 1974-06-03 1976-08-31 Nelson Research & Development Company Method for treating schizophrenia and method and composition for potentiating neuroleptic drugs
US4129652A (en) * 1976-08-16 1978-12-12 Nelson Research & Development Company Method for potentiating neuroleptic drugs
US4138484A (en) * 1976-08-16 1979-02-06 Nelson Research & Development Company Method for treating schizophrenia and method and composition for potentiating neuroleptic drugs

Also Published As

Publication number Publication date
CH625122A5 (en) 1981-09-15
IT7824866A0 (en) 1978-06-22
FR2453643B2 (en) 1984-10-12
FR2453643A2 (en) 1980-11-07

Similar Documents

Publication Publication Date Title
PL205859A1 (en) THE CHILDAL CIRCULAR SYSTEM
BR7702626A (en) PRE-VAPORIZED FUEL SYSTEM
IT8023097A0 (en) NEW TRIPEPTIDAMIDS AGENTS ON THE CENTRAL NERVOUS SYSTEM AND PROCEDURE FOR THEIR PREPARATION.
IT7841622A0 (en) DEVICE TO ACT ON THE CENTRAL NERVOUS SYSTEM USING IMPULSIVE CURRENTS.
NL7805588A (en) 3,3,3-TRIARYLALKYL-4-PHENYLALKYL-4-HYDROXYPIPERIDINS WITH MEDICINAL ACTIVITY.
NL7711446A (en) PHARMACEUTICAL DISINFECTING PREPARATION.
IT7821686A0 (en) PHARMACEUTICAL COMPOSITION.
NO147437C (en) PARTICULAR SUBSTANCE FOR DRUGS.
IT8023096A0 (en) TRIPEPTIDAMIDS AGENTS ON THE CENTRAL NERVOUS SYSTEM AND PROCEDURE FOR THEIR PREPARATION.
NO790313L (en) PHARMACEUTICAL DISSOLUTION.
NL7805747A (en) ACID ALKALICITRATE.
BR7804650A (en) CONNECTION SYSTEM
NL7801464A (en) PHARMACEUTICAL COMPOSITIONS.
IT1096804B (en) PHARMACEUTICAL COMPOSITIONS ACTIVE ON THE CENTRAL NERVOUS SYSTEM
NL7805158A (en) PHARMACEUTICAL PREPARATION.
NL7803804A (en) MIXING SYSTEM.
IT8048322A0 (en) BENZODIAZEPE COMPOUNDS WITH ACTIVITY ON THE CENTRAL NERVOUS SYSTEM AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
NL7812344A (en) PHARMACEUTICAL PREPARATION.
IT1099063B (en) THERAPEUTIC COMPOSITIONS ACTING ON THE CENTRAL NERVOUS SYSTEM
IT1162758B (en) THYENYLMORPHOLINIC DERIVATIVES ACTIVE ON THE CENTRAL NERVOUS SYSTEM
BR7806890A (en) Shelving system
IT7920642A0 (en) HETEROCICLIC DERIVATIVE AS MEDICINAL PRODUCT ACTIVE ON THE CENTRAL NERVOUS SYSTEM AND PROCEDURE FOR ITS PREPARATION.
NL7811642A (en) MEDICINAL PRODUCT ACTING ON THE CENTRAL NERVOUS SYSTEM.
NL7805504A (en) PHARMACEUTICAL PREPARATION.
ZA774376B (en) Pharmaceutical compositions having an action on the central nervous system